• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Res . Coronavirus Disease 2019 (COVID-19) in Children and/or Adolescents: A Meta-Analysis

tetano

Editor, Senior Moderator
Pediatr Res


. 2020 Jun 17.
doi: 10.1038/s41390-020-1015-2. Online ahead of print.
Coronavirus Disease 2019 (COVID-19) in Children and/or Adolescents: A Meta-Analysis


Alessandro Mantovani[SUP] 1 [/SUP], Elisabetta Rinaldi[SUP] 2 [/SUP], Chiara Zusi[SUP] 2 3 [/SUP], Giorgia Beatrice[SUP] 2 [/SUP], Marco Deganello Saccomani[SUP] 4 [/SUP], Andrea Dalbeni[SUP] 5 [/SUP]



Affiliations

Abstract

Background: To assess the overall prevalence of clinical signs, symptoms, and radiological findings in children and/or adolescents with COVID-19.
Methods: We systematically researched in PubMed, Scopus and Web of Science databases observational studies describing COVID-19 in children and/or adolescents until April 11, 2020. Data regarding clinical and radiological features were extracted from eligible studies and meta-analysis was performed using random-effects modeling.
Results: We examined 19 eligible studies for a total of 2855 children and/or adolescents with COVID-19. Approximately 47% of subjects had fever (95% confidence interval [CI] 22-72%; I[SUP]2[/SUP] = 98.6%), 37% cough (95%CI 15-63%; I[SUP]2[/SUP] = 98.6%), 4% diarrhea (95%CI 0-12%; I[SUP]2[/SUP] = 92.2%), 2% nasal congestion (95%CI 0-7%; I[SUP]2[/SUP] = 87.7%), 1% dyspnea (95%CI 0-7%; I[SUP]2[/SUP] = 91.5%) and 0% abdominal pain (95%CI 0-1%; I[SUP]2[/SUP] = 76.3%). Subjects presented mild symptoms in 79% (95%CI 65-91%; I[SUP]2[/SUP] = 93.5%) of cases, whereas only 4% (95%CI 1-9%; I[SUP]2[/SUP] = 76.4%) were critical. Among those with pneumonia on computed tomography, 26.4% (95%CI 13-41%; I[SUP]2[/SUP] = 80.8%) presented a unilateral involvement, 16% (95%CI 5-29%, I[SUP]2[/SUP] = 81.2%) had bilateral involvement and 9% (95%CI 0-24%; I[SUP]2[/SUP] = 88.7%) had interstitial pneumonia.
Conclusions: Children and/or adolescents tend to have a mild COVID-19 course with a good prognosis.
Impact: Compared to adults, children and/or adolescents tend to have a mild COVID-19 course with a good prognosis. This study provides new and consistence information on the clinical and radiological characteristics of COVID-19 in pediatrics. This study may help to fight COVID-19 in pediatric population.
 
Back
Top Bottom